Geneva, World Health Organization, 2026. 94p.
Provides the most comprehensive and up-to-date assessment of the global burden of hepatitis B (HBV) and hepatitis C (HCV). Also highlights the progress in response efforts at global, regional and country levels, in the context of global commitments, strategies and targets.
New York, HealthCentral, 2024.
HCV increases the chances of developing fatty liver disease. Stresses the importance of screening and treatment/management.
Westend, GL Research Features, 2020.
Fatty liver can impact the disease course of CHB. Regular assessments are especially important in patients with metabolic risk factors.
Canberra, Healthdirect Australia, 2026.
Provides information about the condition and its management. Includes links to other credible sources of information and services.
Melbourne,GESA, 2024.
Provides information about the disease and it's management. Has detailed dietary advice, including a checklist. Available in Arabic, Chinese (Simp), Chinese (Trad), English, Vietnamese.
Pleasanton, CA, Baishideng Publishing Group, 2018.
Found that fatty liver is very common in hepatitis C virus (HCV) patients post-SVR. Long term follow up is needed to assess steatosis and fibrosis in HCV patients post-SVR.
Adelaide, Hepatitis SA, 2026. Blog post.
A clinical trial led by the Kirby Institute at UNSW Sydney has found that point-of-care testing for hepatitis B DNA is as effective as traditional laboratory testing, paving the way for faster diagnosis and treatment in hard-to-reach communities, as well as with the broader population.
Sydney, Hepatitis NSW, 2025. Poster.
Highlights the effectiveness of peer-led outreach and Dried Blood Spot testing for engaging priority populations who may otherwise not access hepatitis C testing and care. Peer workers were critical to building trust, increasing participation, and supporting people through treatment pathways. Strong partnerships with community services and Local Health Districts also improved access and follow-up outcomes.
London, LiverUK, 2026.
Guide to healthy eating and moderate activity for people who need to manage fatty liver disease.
Melbourne, Liver Foundation, 2026.
Includes information on managing fatty liver disease through diet with recipes, meal modifications and personal stories. Also includes a 12 week support programme by email.
Ontario, Liver Canada, 2026. 4p.
Recipes and tips suitable for people who need to manage their liver health.
Ontario, Liver Canada, 2023. 12p.
Recipes and tips suitable for people who need to manage their liver health.
Adelaide, Cancer Council SA, 2026. Webpage.
A balanced diet featuring plenty of vegetables and fibre can lower your risk of cancer. Provides a collection of downloadable recipes books featuring health and easy meals.
Zurich,INHSU,2026. Blog post.
Rafaela Rigoni, Head of Research at Correlation – European Harm Reduction Network, reflects on her experience working across Brazil, Latin America, and Europe, and explores what global harm reduction efforts can learn from Latin America’s rights based, community-driven approaches.
Australia, Croakey, 2026. Article and video.
Uncle Kerry Fox, a Stolen Generations Survivor, shares his story about being diagnosed with and treated for liver cancer. Includes a video he recorded for Liver Cancer Awareness Week.
Geneva, World Hepatitis Alliance, 2026. 36p.
Hepatitis remains a major global health threat, despite some gains through vaccines and treatment. With time running out before 2030, we must act now to stop rising deaths. We need to quickly expand access to testing, treatment, safe injections, and newborn vaccinations to achieve elimination.
For enquiries or feedback, please contact the librarian at Librarian@hepatitissa.asn.au.
| Address: | 3 Hackney Road Hackney SA 5069 |
| Phone: | (08) 8362 8443 |
| Fax: | (08) 8362 8559 |
| Email: | Librarian@hepatitissa.asn.au |
| Post: | PO Box 782 Kent Town SA 5071 |
Monday – Friday
9am to 5pm
Hepatitis SA is a non-profit, community-based organisation that provides information, education and support services to South Australians affected by hepatitis B and hepatitis C.